Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections

H Sies, MJ Parnham - Free Radical Biology and Medicine, 2020 - Elsevier
Ebselen is an organoselenium compound exhibiting hydroperoxide-and peroxynitrite-
reducing activity, acting as a glutathione peroxidase and peroxiredoxin enzyme mimetic …

Understanding the hepatitis C virus life cycle paves the way for highly effective therapies

TKH Scheel, CM Rice - Nature medicine, 2013 - nature.com
More than two decades of intense research has provided a detailed understanding of
hepatitis C virus (HCV), which chronically infects 2% of the world's population. This effort has …

Hepatitis C virus proteins: from structure to function

D Moradpour, F Penin - Hepatitis C virus: from molecular virology to …, 2013 - Springer
Great progress has been made over the past years in elucidating the structure and function
of the hepatitis C virus (HCV) proteins, most of which are now actively being pursued as …

Benzothiazoles as potential antiviral agents

YI Asiri, A Alsayari, AB Muhsinah… - Journal of Pharmacy …, 2020 - academic.oup.com
Objectives The recent viral pandemic poses a unique challenge for healthcare providers.
Despite the remarkable progress, the number of novel antiviral agents in the pipeline is …

Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic

X Ren, L Zou, J Lu, A Holmgren - Free Radical Biology and Medicine, 2018 - Elsevier
Thioredoxin system is a ubiquitous disulfide reductase system evolutionarily conserved
through all living organisms. It contains thioredoxin (Trx), thioredoxin reductase (TrxR) and …

Viral proteins recognized by different TLRs

R Zhou, L Liu, Y Wang - Journal of Medical Virology, 2021 - Wiley Online Library
Virus invasion activates the host's innate immune response, inducing the production of
numerous cytokines and interferons to eliminate pathogens. Except for viral DNA/RNA, viral …

Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)

F McPhee, AK Sheaffer, J Friborg… - Antimicrobial agents …, 2012 - Am Soc Microbiol
ABSTRACT Asunaprevir (ASV; BMS-650032) is a hepatitis C virus (HCV) NS3 protease
inhibitor that has demonstrated efficacy in patients chronically infected with HCV genotype 1 …

New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives

C Welsch, A Jesudian, S Zeuzem, I Jacobson - Gut, 2012 - gut.bmj.com
Until recently, the standard of care (SOC) for patients with chronic hepatitis C virus (HCV)
infection has consisted of a combination of pegylated interferon-N1 plus ribavirin …

Single-molecule analysis and engineering of DNA motors

S Mohapatra, CT Lin, XA Feng, A Basu, T Ha - Chemical reviews, 2019 - ACS Publications
Molecular motors are diverse enzymes that transduce chemical energy into mechanical
work and, in doing so, perform critical cellular functions such as DNA replication and …

Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus

K Morikawa, CM Lange, J Gouttenoire… - Journal of viral …, 2011 - Wiley Online Library
Hepatitis C virus (HCV) nonstructural protein 3‐4A (NS3‐4A) is a complex composed of NS3
and its cofactor NS4A. It harbours serine protease as well as NTPase/RNA helicase …